5 Ways Biomarker Testing Guides AML Treatment
Biomarker testing is transforming AML treatment by providing information that guides therapy selection. Here are five ways it helps.
First, targeted therapy selection. Mutations such as FLT3 and IDH guide the use of specific inhibitors. Second, prognosis. Certain mutations indicate favorable or poor outcomes. Third, risk stratification. Testing helps classify patients into risk groups. Fourth,...
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek